1. Home
  2. SDHC vs EVO Comparison

SDHC vs EVO Comparison

Compare SDHC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Douglas Homes Corp.

SDHC

Smith Douglas Homes Corp.

HOLD

Current Price

$19.93

Market Cap

176.7M

Sector

N/A

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.94

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDHC
EVO
Founded
2008
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.7M
1.1B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
SDHC
EVO
Price
$19.93
$2.94
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$16.70
$7.00
AVG Volume (30 Days)
79.3K
137.3K
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$998,173,000.00
$887,396,457.00
Revenue This Year
$0.47
N/A
Revenue Next Year
$7.65
$8.80
P/E Ratio
N/A
N/A
Revenue Growth
10.26
N/A
52 Week Low
$15.00
$2.84
52 Week High
$32.50
$5.10

Technical Indicators

Market Signals
Indicator
SDHC
EVO
Relative Strength Index (RSI) 52.23 38.55
Support Level $19.48 $2.94
Resistance Level $23.49 $3.05
Average True Range (ATR) 1.29 0.10
MACD -0.14 0.01
Stochastic Oscillator 14.16 18.67

Price Performance

Historical Comparison
SDHC
EVO

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: